Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes
FULL MENU

Unravelling chronic obstructive pulmonary disease

Unravelling chronic obstructive pulmonary disease

BACK

Unravelling chronic obstructive pulmonary disease

The chronic lung disease COPD affects between 4-10% of Europeans, but about 70% of them are underdiagnosed: a major public health problem. By developing a simulation environment of the respiratory system and creating a decision-support system for clinicians, the European research project SYNERGY-COPD wants to improve diagnosis and management of the disease. The system allows doctors to anticipate the progression of COPD and to determine the most suitable treatment for each COPD patient. Doctors can also make use of a patented algorithm, developed within the project, to assess the quality of the Spirometry tests of their patients.

Three clinical studies were conducted: a retrospective study on two databases of 13 and 5 million patients; a prospective study on over 400 COPD patients; and a third combining these two. The results indicate the high potential of a systems approach to address COPD heterogeneity. Significant knowledge gaps were identified that are relevant to shape strategies to foster 4P Medicine for patients with COPD.

Fermoselle C, Rabinovich R, Ausín P, Puig-Vilanova E, Coronell C, Sanchez F, Roca J, Gea J, Barreiro E. Does oxidative stress modulate limb muscle atrophy in severe COPD patients? Eur Respir J. 2012 Oct;40(4):851-62
Rodriguez DA, Kalko S, Puig-Vilanova E, Perez-Olabarría M, Falciani F, Gea J, Cascante M, Barreiro E, Roca J. Muscle and blood redox status after exercise training in severe COPD patients. Free Radic Biol Med. 2012 Jan 1;52(1):88-94.
Public dissemination: SYNERGY-COPD - http://www.youtube.com/watch?v=RUbC50UoHfQ

IMAGE GALLERY:

NEWS

News Avicenna Alliance at RAPS meeting in Pittsburgh

Avicenna Alliance at RAPS meeting in Pittsburgh

On October 8th, various key members of the Avicenna Alliance including Marc Horner, International Affairs WG leader, Martha de Cuhna, Policy Development WG Leader, and our new partner Surash Surash from the leading Notified Body TüV SüD, spoke at the Regulatory Affairs Professional Society (RAPS) meeting in Pittsburgh to highlight the essential and increasing role of in silico methods throughout the total product life cycle of medical devices.

News Avicenna Alliance Welcomes the Notified Body TÜV SÜD as a New Partner

Avicenna Alliance Welcomes the Notified Body TÜV SÜD as a New Partner

The Avicenna Alliance is delighted to welcome TÜV SÜD as its newest Partner. TÜV SÜD is a leading Notified Body operating across multiple regulatory territories, including the EU, the United States, the UK, and Asia. With more than 150 years of experience, a presence in 1,000 locations worldwide, and over 30,000 employees, TÜV SÜD is a trusted global partner in testing, inspection, certification, and training solutions.

News The Alliance at the iSi Health Symposium

The Alliance at the iSi Health Symposium

On 11 and 12 September 2025, our partner iSi Health, Erica Beaucage-Gauvreau and Rocio Castro Vinuelas, organised an excellent symposium in Leuven to bring together key players in the in silico community and promote networking, brainstorming and exchanges.

Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2025 Avicenna Alliance | powered by We Berry